Literature DB >> 3525677

Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.

E H De Titto, J R Catterall, J S Remington.   

Abstract

Activated macrophages produce tumor necrosis factor (TNF), a cytokine with anti-tumor and anti-plasmodia activities. This study revealed that recombinant TNF (rTNF) inhibits intracellular multiplication of blood trypomastigotes of Trypanosoma cruzi in murine peritoneal macrophages. rTNF did not have any apparent direct effect on the survival of extracellular T. cruzi or on its ability to infect mammalian cells. The degree of inhibition of the intracellular multiplication of T. cruzi was found to be a function of the time of exposure of the infected cells to rTNF. rTNF induced a comparable effect when different strains of the parasite were used. In contrast to its activity on T. cruzi, rTNF did not affect intracellular multiplication of Toxoplasma gondii tachyzoites or bradyzoites in normal murine peritoneal macrophages or in human fibroblasts. Killing of Toxoplasma tachyzoites by activated macrophages was not enhanced by rTNF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525677

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Further investigation of anticoccidial activity of 7-bromo-N-(2-imidazolidinylidene)-1H-indazol-6-amine.

Authors:  A P Ricketts; J W McFarland; D M Newcomb; J A Olson; J R Rice
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor.

Authors:  D Chatterjee; A D Roberts; K Lowell; P J Brennan; I M Orme
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

Authors:  C A Hunter; T Slifer; F Araujo
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Authors:  Kelly J Pittman; Laura J Knoll
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

Review 6.  Use of immune modulators in nonspecific therapy of bacterial infections.

Authors:  M T Vogels; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

7.  c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages.

Authors:  A Descoteaux; G Matlashewski
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

8.  Effect of recombinant tumour necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi.

Authors:  C M Black; D M Israelski; Y Suzuki; J S Remington
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

9.  Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.

Authors:  J S Silva; G N Vespa; M A Cardoso; J C Aliberti; F Q Cunha
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  M5, a phosphoinositol-linked human myelomonocytic activation-associated antigen.

Authors:  S J Gadd; O Majdic; W Kasinrerk; H Stockinger; D Maurer; R Eher; W Knapp
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.